Reed Vaughn Tuckson
CIK 1511051 · EVP & Chief of Medical Affairs · last filed 2026-03-09
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$1.02M
Companies
5
Total Filings
54
Lifetime Open-Market Net
-$22.45M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| HSIC | Director | 12,520 | $81.25 | $1.02M | $0 | 8 | 2026-03-09 |
| Adverum Biotechnologies, Inc. (ADVM) Delisted | Director | — | $4.36 | — | $0 | 6 | 2025-12-10 |
| CTI BIOPHARMA CORP (CTIC) Delisted | Director | 0 | $9.09 | $0 | $0 | 13 | 2023-06-26 |
| CTI BIOPHARMA CORP (TRGT) Delisted | Director | 536,662 | — | — | $0 | 10 | 2014-01-31 |
| UNITEDHEALTH GROUP INC (UNHw) Delisted | EVP & Chief of Medical Affairs | 116,943 | — | — | -$22.45M | 12 | 2012-06-07 |
Recent Filings · Page 3 of 6
54 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2018-11-20 | — | Disp (D) | −8,311 | $0 | |
| 2018-06-08 | — | Mixed | +2,284 | $0 | |
| 2018-05-17 | CTI BIOPHARMA CORP (CTIC) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-06-09 | — | Grant (A) | — | $0 | |
| 2017-05-02 | CTI BIOPHARMA CORP (CTIC) Delisted | Exer (M) | +34,736 | $0 | EDGAR |
| 2017-02-27 | CTI BIOPHARMA CORP (CTIC) Delisted | Grant (A) | — | $0 | EDGAR |
| 2016-06-10 | — | Grant (A) | — | $0 | |
| 2016-04-29 | CTI BIOPHARMA CORP (CTIC) Delisted | Mixed | +63,695 | $0 | EDGAR |
| 2015-12-31 | CTI BIOPHARMA CORP (CTIC) Delisted | Grant (A) | — | $0 | EDGAR |
| 2015-12-11 | CTI BIOPHARMA CORP (CTIC) Delisted | Disp (D) | −58,320 | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.